References
- Albain KS, Crowley JJ, LeBlanc M, et al (1990). Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient southwest oncology group data base. J Clin Oncol, 8, 1563-74.
- Albain KS, Crowley JJ, LeBlanc M, et al (1991). Survival determinants in extensive-stage non-small-cell lung cancer: the southwest oncology group experience. J Clin Oncol, 9, 1618-26.
- Behera D, Balamugesh T (2004). Lung cancer in India. Indian J Chest Dis Allied Sci, 46, 269-81.
- Blanchon F, Grivaux M, Asselain B, et al (2006). 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol, 7, 829-36. https://doi.org/10.1016/S1470-2045(06)70868-3
- Cetin K, Ettinger DS, Hei Y-J, et al (2011). Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program. Clin Epidemiol, 3, 139-48.
- Cooper WA, O'toole S, Boyer M, et al (2011). What' new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Pathology, 43, 103-15. https://doi.org/10.1097/PAT.0b013e328342629d
- Cykert S, Dilworth-Anderson P, Monroe MH, et al (2010). Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA, 303, 2368-76. https://doi.org/10.1001/jama.2010.793
- Delaney G, Jacob S, Featherstone C, et al (2005). The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer, 104, 1129-37. https://doi.org/10.1002/cncr.21324
- Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. https://doi.org/10.1016/j.ejca.2008.10.026
- Erridge SC, Murray B, Price A, et al (2008). Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol, 3, 491-8. https://doi.org/10.1097/JTO.0b013e31816fca46
- Esnaola NF, Gebregziabher M, Knott K, et al (2008). Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg, 86, 220-6. https://doi.org/10.1016/j.athoracsur.2008.02.072
- Ettinger DS. NCCN Clinical Practice Guidelines in Oncology for Non Small Cell Lung Cancer, Ver 2.2012 [Internet]. Natinal Comprehensive Cancer Network; 2012. Available from: www.nccn.com
- Field RW, Smith BJ, Platz CE, et al (2004). Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst, 96, 1105-7. https://doi.org/10.1093/jnci/djh189
- Fry WA, Phillips JL, Menck HR.(1999). Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer, 86, 1867-76. https://doi.org/10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9
- Giovino GA (2002). Epidemiology of tobacco use in the United States. Oncogene, 21, 7326-40. https://doi.org/10.1038/sj.onc.1205808
- Govindan R, Page N, Morgensztern D, et al (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44. https://doi.org/10.1200/JCO.2005.04.4859
- Grivaux M, Zureik M, Marsal L, et al.(2011). Five-year survival for lung cancer patients managed in general hospitals. Rev Mal Respir, 28, 31-8. https://doi.org/10.1016/j.rmr.2008.07.001
- Janssen-Heijnen MLG, Coebergh J-WW (2003). The changing epidemiology of lung cancer in Europe. Lung Cancer, 41, 245-58. https://doi.org/10.1016/S0169-5002(03)00230-7
- Khan NA, Afroz F, Lone MM, et al (2006). Profile of lung cancer in Kashmir, India: a five-year study. Indian J Chest Dis Allied Sci, 48, 187-90.
- Mahmud SM, Reilly M, Comber H (2003). Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer, 41, 57-64. https://doi.org/10.1016/S0169-5002(03)00148-X
- Mohan A, Goyal A, Singh P, et al (2006). Survival in small cell lung cancer in India: prognostic utility of clinical features, laboratory parameters and response to treatment. Indian J Cancer, 43, 67-74. https://doi.org/10.4103/0019-509X.25887
- Parkin DM FJ. GLOBOCAN 2008 V1.2, Cancer Incidence and Mortality Worldwide [Internet]. IARC Cancer Base No.10; Available from: http://globocan.iarc.fr
- Prasad R, James P, Kesarwani V, et al (20004). Clinicopathological study of bronchogenic carcinoma. Respirology, 9, 557-60. https://doi.org/10.1111/j.1440-1843.2004.00600.x
- Scagliotti G, Brodowicz T, Shepherd FA, et al (2011). Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. J Thorac Oncol, 6, 64-70
- Singh N, Aggarwal AN, Gupta D, et al (2010). Unchanging clinico-epidemiological profile of lung cancer in north India over three decades. Cancer Epidemiol, 34, 101-4. https://doi.org/10.1016/j.canep.2009.12.015
- Standfield L, Weston AR, Barraclough H, et al (2011). Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence. Respirology, 16, 1210-20. https://doi.org/10.1111/j.1440-1843.2011.02025.x
- Stevens W, Stevens G, Kolbe J, et al (2007). Lung cancer in New Zealand: patterns of secondary care and implications for survival. J Thorac Oncol, 2, 481-93. https://doi.org/10.1097/JTO.0b013e31805fea3a
- Thun MJ, Henley SJ, Burns D, et al. (2006). Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst, 98, 691-9. https://doi.org/10.1093/jnci/djj187
- Valaitis J, Warren S, Gamble D (1981). Increasing incidence of adenocarcinoma of the lung. Cancer, 47, 1042-6. https://doi.org/10.1002/1097-0142(19810301)47:5<1042::AID-CNCR2820470535>3.0.CO;2-5
- Vineis P, Alavanja M, Buffler P, et al (2004). Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst, 96, 99-106. https://doi.org/10.1093/jnci/djh014
- Vinod SK, O’Connell DL, Simonella L, et al (2008). Gaps in optimal care for lung cancer. J Thorac Oncol, 3, 871-9. https://doi.org/10.1097/JTO.0b013e31818020c3
- Vinod SK, Sidhom MA, Gabriel GS, et al (2010). Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol, 5, 1025-32.
- Wakelee HA, Chang ET, Gomez SL, et al (2007). Lung cancer incidence in never smokers. J Clin Oncol, 25, 472-8. https://doi.org/10.1200/JCO.2006.07.2983
Cited by
- Prognostic Value of Phosphorylated mTOR/RPS6KB1 in Non-small Cell Lung Cancer vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3725
- Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination vol.14, pp.7, 2013, https://doi.org/10.7314/APJCP.2013.14.7.4369
- Edition Staging System vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2465
- Hematologic Toxicity in Patients Undergoing Radical Anti-cancer Therapy: A Cross-Sectional Analysis of Patients in an Oncology Ward in India vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3587
- Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4891
- Association of p53 and mdm2 in the development and progression of non-small cell lung cancer vol.36, pp.7, 2015, https://doi.org/10.1007/s13277-015-3208-6
- Role of survivin re-expression in the development and progression of non-small cell lung cancer vol.36, pp.7, 2015, https://doi.org/10.1007/s13277-015-3224-6
- Clinico-Pathological Profile and Haematological Abnormalities Associated with Lung Cancer in Bangalore, India vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8235
- Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung vol.37, pp.2, 2016, https://doi.org/10.1097/MNM.0000000000000422
- Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a Phase II randomized study vol.89, pp.1062, 2016, https://doi.org/10.1259/bjr.20150966
- Surgery for lung cancer—the Indian scenario vol.34, pp.S1, 2018, https://doi.org/10.1007/s12055-017-0634-7